An intact cysteine-rich domain is required for dystrophin function.
Open Access
- 1 August 1992
- journal article
- case report
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 90 (2) , 666-672
- https://doi.org/10.1172/jci115909
Abstract
The carboxyl terminus of dystrophin is encoded by a highly conserved, alternatively spliced region of the gene. The few rare mutations reported in this region are of interest in unraveling the function of the dystrophin molecule. An unusual case of infantile onset Duchenne muscular dystrophy (DMD) with an internal 3' genomic deletion, and a membrane localized non-functional dystrophin protein, was used to explore the functional activity of this region. The patient's cDNA sequence showed an intragenic 1824-bp deletion precisely excising the cysteine rich and alternatively spliced COOH-terminal domains of dystrophin. The unaltered final 2.7 kb of the patients transcript was defined as a single exon localized to two genomic fragments, with the 5.9 kb HindIII fragment containing the stop codon. To understand the significance of deletions in this important region of the dystrophin gene, we mapped the order and cDNA coordinates for the 3' genomic HindIII fragments encoding the cysteine rich and alternative splicing domains. This 3' gene map was used to compare the clinical phenotype of the other reported COOH-terminal deletions in the literature. Our analysis concludes that the cysteine-rich domain confers an important function for the dystrophin protein.Keywords
This publication has 34 references indexed in Scilit:
- Is the carboxyl‐terminus of dystrophin required for membrane association? A novel, severe case of duchenne muscular dystrophyAnnals of Neurology, 1991
- Human dystrophin expression in mdx mice after intramuscular injection of DNA constructsNature, 1991
- Different localization of dystrophin in developing and adult human skeletal muscleMuscle & Nerve, 1991
- Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNAThe Lancet, 1990
- Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophiesCell, 1990
- Increased Activity of Calcium Leak Channels in Myotubes of Duchenne Human and mdx Mouse OriginScience, 1990
- IMMUNOLOGICAL STUDY OF DYSTROPHIN IN DUCHENNE FETUSThe Lancet, 1989
- Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia.Journal of Clinical Investigation, 1989
- Characterization of Dystrophin in Muscle-Biopsy Specimens from Patients with Duchenne's or Becker's Muscular DystrophyNew England Journal of Medicine, 1988
- Fluorescence detection in automated DNA sequence analysisNature, 1986